Broader Transparency on Risk-benefit Assessment of the Bial Trial in France
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 15, Issue 7
Abstract
On 11 January 2016, a Phase I trial of an experimental fatty acid amide hydrolase inhibitor for pain developed by Bial-Portela was halted after six healthy volunteers were admitted to the University of Rennes Hospital in France. One volunteer died and four suffered severe neurological injuries. It is a dreadful reminder of the Tenegero trial that also hospitalized six volunteers in 2006. Three major similarities were observed between the Tegenero and Bial trials. The first similarity is related to the dosing interval protocol. There is a lack of information about whether the multiple-dose regimen included adequate time intervals between individuals receiving the drug. The second similarity is on the dosing calculation that was based on the ‘no adverse effect level’ (NOAEL). The third similarity is observed in terms of how there was no prior publication of preclinical findings in the public domain before the start of both trials. There have been calls for the full release of the Investigation Medicinal Product Dossier and the Investigator’s Brochure, as these data are critical to maximize patient safety in the future and should outweigh considerations of commercial confidentiality. Likewise, it is necessary for the Brest Regional Ethics Committee to release its documents, which captured the risk-benefit assessment in approving the Bial trial, for external scrutiny.
Authors and Affiliations
William Wei Lim Chin
Keywords
Related Articles
- EP ID EP341437
- DOI 10.9734/BJMMR/2016/26077
- Views 72
- Downloads 0
Practice of Effective Hand Washing and Associated Factors among Caregivers of Infants Attending Infant Welfare Clinics in Ado-Ekiti, Ekiti State, Nigeria
Introduction: Effective hand washing has been shown to reduce the incidence of some infectious diseases especially diarrhea and respiratory diseases among infants and under five children. The aim of this study was to ass...
Stabilization of Prostate Cancer with Amanita phalloides: Intervals with 5-Alpha-Reductase Inhibitors and Melatonin to Circumvent Resistance: Case Report
Aims: Amanita phalloides contains alpha-amanitin, inhibiting RNApolymeraseII. Due to overexpression of switch genes in tumor cells, RNApolymeraseII is used to full extent there. Partial inhibition with amanitin influence...
Efficacy of Long-term Effect and Repeat Intraarticular Botulinum toxin in Patients with Painful Total Joint Arthroplasty: A Retrospective Study
Objective: Based on recent success of intra-articular (IA) Botulinum neurotoxin type A (BoNT/A; OnabotulinumtoxinA) in patients with osteoarthritis, we examined if repeat IA-BoNT/A is an effective antinociceptive in pat...
Roles of CD5+, CD19+, CD41a+, CD55+ and CD59+ in Chronic Immune Thrombocytopenic Purpura (ITP)
Aims: The aim of this study was to investigate of the roles of CD5+ and CD19+ on lymphocytes, CD5+ on B lymphocytes, CD41a+ on platelets and CD55+ and CD59+ on erythrocytes in platelet destruction; and evaluate them acco...
Obtaining Dental Aesthetics for Lower Incisor Agenesis
Tooth agenesis is a congenital disorder, which is extremely rare in lateral mandibular incisors. This article presents the case of a female patient with the absence of right lower lateral incisor and significant Bolton d...